Correlation Between Krystal Biotech and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Krystal Biotech and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Hepion Pharmaceuticals.
Diversification Opportunities for Krystal Biotech and Hepion Pharmaceuticals
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Krystal and Hepion is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Krystal Biotech and Hepion Pharmaceuticals
Given the investment horizon of 90 days Krystal Biotech is expected to generate 0.38 times more return on investment than Hepion Pharmaceuticals. However, Krystal Biotech is 2.63 times less risky than Hepion Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 7,780 in Krystal Biotech on November 2, 2024 and sell it today you would earn a total of 8,331 from holding Krystal Biotech or generate 107.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Krystal Biotech vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Krystal Biotech |
| Hepion Pharmaceuticals |
Krystal Biotech and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Krystal Biotech and Hepion Pharmaceuticals
The main advantage of trading using opposite Krystal Biotech and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Krystal Biotech vs. MeiraGTx Holdings PLC | Krystal Biotech vs. Apellis Pharmaceuticals | Krystal Biotech vs. Regenxbio | Krystal Biotech vs. Rhythm Pharmaceuticals |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |